healthsystemCIO.com is the sole online-only publication dedicated to exclusively and comprehensively serving the information needs of healthcare CIOs.
Despite the myriad benefits, including increased patient engagement, telehealth remains an option, not an imperative. As a result, “we are still underperforming as an industry compared to the promises made and the vision we’ve spun,” said Joseph Kvedar, MD. In this piece he examines why that’s the case and how healthcare can turn the tide.
By ‘red-flagging’ prescriptions that come from telehealth providers in other states, the proposed DEA rules may “inadvertently create barriers to care,” said Joseph Kvedar, MD. In this piece, he discusses recommendations from the ATA to help build pharmacists’ trust in filling remote prescriptions.
Rather than comparing telehealth services to office visits in terms of data collection – which is future – perhaps we should focus on integrating virtual care into the overall care picture, said Dr. Joe Kvedar in this piece. “It is time for telehealth to sit at the grownup’s table and be treated like an honest service.
Telehealth has come a long way since the Covid-induced boom, but a lot hinges on its continued success, according to Joseph Kvedar, MD. In this piece, he examines the impact it has had, the vision for what telehealth can be, and the steps organizations can take to get there.
If telehealth can consistency provide a convenient virtual environment, as well as a clinical workflow that identifies which patients and conditions are appropriate for telehealth services, it’s far more likely to be able to compete with in-person care, according to Joseph Kvedar, MD, Senior Advisor, at the MGH Center for Innovation.
With the public health emergency scheduled to expire, the DEA has proposed rules that put patients at risk of “not getting critical, clinically appropriate medications, which in turn puts their lives at risk,” said Dr. Joseph Kvedar. In this blog, he provides information on how leaders can get involved and help prevent a “potential public health crisis.”
The key to restoring trust in telehealth is in addressing the “underlying issues that are raising concerns in the first place,” according to Joseph Kvedar, MD. In this blog, he discusses the steps the ATA is taking, and the lessons healthcare can learn from other industries.
In the past year, our blogs have examined a variety of pertinent topics, from clinical informatics to artificial intelligence to the ever-evolving CIO role. Here, we unveil the most popular blog posts from our contributing authors.
The answer to the most basic question surrounding telehealth — ‘Is it as good as in-person care?’ — is anything but simple, according to Dr. Joseph Kvedar. In this piece, he examines the pros and cons of different types of clinical research and shares examples from recent literature that can help uncover some answers.
The problem with digital health adoption? Developers (especially startups) want to move quickly, whereas physicians want to see evidence, which can be “time-consuming and expensive to obtain,” according to Joseph Kvedar, MD.
